A trailblazer in the next wave of health and wellness, Lixir Labs is developing industry-leading breathing products to treat the most common mental health conditions of our time.

Our vision encompasses a dual ambition. Firstly, to create the world's premier technology for transformative breathing and visualization, offering unparalleled, immersive experiences that unlock new realms of personal growth and self-care for our users. Secondly, to develop the first breathwork-focused consumer-packaged goods (CPG) in the industry, carving out a new sector in the rapidly growing world of breath therapy—the fastest-growing health and wellness modality on the planet.

Fueled entirely by the commitment and capital of our founders, Lixir Labs has progressed to this point without outside funding, underscoring our deep dedication to our mission. We are at a pivotal moment, poised for robust growth. As we shift towards realizing our impact-driven goals, we're inviting investors who share our excitement and vision to join us on this journey. Our immediate plans include a strategic focus on scaling through judicious paid acquisition, the development of our new iPhone, Android, and Web app, integrating AI for bespoke user experiences, and crafting new in-app and social media content that captivates and transforms.

This vision is not just aspirational—it’s underway.

Marked not only by the enthusiastic early feedback from users engaging with our transformative experiences, but also by our first-mover status as creators of the world's first breathwork-focused CPG, our Breath Balm product line. This dual-path uniquely positions Lixir Labs to be a dominant force in the emerging breath therapy market.